Natural killer cells and antifungal host response

Clinical and Vaccine Immunology

Volumn 20, Issue 4, 2013, Pages 452-458

  Schmidt, Stanislaw ^a   Zimmermann, Stefanie Yvonne ^a   Tramsen, Lars ^a   Koehl, Ulrike ^b   Lehrnbecher, Thomas ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PERFORIN;

ANTIFUNGAL ACTIVITY; DISEASE MODEL; FUNGUS IMMUNITY; HELPER CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ANIMALS; DISEASE MODELS, ANIMAL; FUNGI; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MICE; MYCOSES;

EID: 84876488766     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00606-12     Document Type: Review

References (91)

1. Langers I, Renoux VM, Thiry M, Delvenne P, Jacobs N. 2012. Natural killer cells: Role in local tumor growth and metastasis. Biologics 6:73-82.
2. Wood SM, Ljunggren HG, Bryceson YT. 2011. Insights into NK cell biology from human genetics and disease associations. Cell. Mol. Life Sci. 68:3479-3493.
3. Cho D, Shook DR, Shimasaki N, Chang YH, Fujisaki H, Campana D. 2010. Cytotoxicity of activated natural killer cells against pediatric solid tumors. Clin. Cancer Res. 16:3901-3909.
4. Biron CA, Su HC, Orange JS. 1996. Function and regulation of natural killer (NK) cells during viral infections: Characterization of responses in vivo. Methods 9:379-393.
5. Lieke T, Graefe SE, Klauenberg U, Fleischer B, Jacobs T. 2004. NK cells contribute to the control of Trypanosoma cruzi infection by killing free parasites by perforin-independent mechanisms. Infect. Immun. 72:6817-6825.
6. Small CL, McCormick S, Gill N, Kugathasan K, Santosuosso M, Donaldson N, Heinrichs DE, Ashkar A, Xing Z. 2008. NK cells play a critical protective role in host defense against acute extracellular Staphylococcus aureus bacterial infection in the lung. J. Immunol. 180:5558-5568.
7. Bouzani M, Ok M, McCormick A, Ebel F, Kurzai O, Morton CO, Einsele H, Loeffler J. 2011. Human NK cells display important antifungal activity against Aspergillus fumigatus, which is directly mediated by IFNgamma release. J. Immunol. 187:1369-1376.
8. Hidore MR, Nabavi N, Reynolds CW, Henkart PA, Murphy JW. 1990. Cytoplasmic components of natural killer cells limit the growth of Cryptococcus neoformans. J. Leukoc. Biol. 48:15-26.
9. Hidore MR, Nabavi N, Sonleitner F, Murphy JW. 1991. Murine natural killer cells are fungicidal to Cryptococcus neoformans. Infect. Immun. 59:1747-1754.
10. Jimenez BE, Murphy JW. 1984. In vitro effects of natural killer cells against Paracoccidioides brasiliensis yeast phase. Infect. Immun. 46:552-558.
11. Levitz SM, Dupont MP, Smail EH. 1994. Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infect. Immun. 62:194-202.
12. Ma LL, Wang CL, Neely GG, Epelman S, Krensky AM, Mody CH. 2004. NK cells use perforin rather than granulysin for anticryptococcal activity. J. Immunol. 173:3357-3365.
13. Marr KJ, Jones GJ, Zheng C, Huston SM, Timm-McCann M, Islam A, Berenger BM, Ma LL, Wiseman JC, Mody CH. 2009. Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Infect. Immun. 77: 2436-2446.
14. Murphy JW, Hidore MR, Wong SC. 1993. Direct interactions of human lymphocytes with the yeast-like organism, Cryptococcus neoformans. J. Clin. Invest. 91:1553-1566.
15. Murphy JW, McDaniel DO. 1982. In vitro reactivity of natural killer (NK) cells against Cryptococcus neoformans. J. Immunol. 128:1577-1583.
16. Scaringi L, Blasi E, Rosati E, Marconi P, Bistoni F. 1991. Fungicidal activity of Candida albicans-induced murine lymphokine-activated killer cells against C. albicans hyphae in vitro. J. Gen. Microbiol. 137:2851-2856.
17. Schmidt S, Tramsen L, Hanisch M, Latge JP, Huenecke S, Koehl U, Lehrnbecher T. 2011. Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J. Infect. Dis. 203:430-435.
18. Schmidt S, Tramsen L, Perkhofer S, Lass-Florl C, Hanisch M, Roger F, Klingebiel T, Koehl U, Lehrnbecher T. 2 November 2012. Rhizopus oryzae hyphae are damaged by human natural killer (NK) cells, but suppressNKcell mediated immunity. Immunobiology [Epub ahead of print.] doi:10.1016/j.imbio.2012.10.013.
19. Kawakami K, Koguchi Y, Qureshi MH, Miyazato A, Yara S, Kinjo Y, Iwakura Y, Takeda K, Akira S, Kurimoto M, Saito A. 2000. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFNgamma production by NK cells. J. Immunol. 165:941-947.
20. Kawakami K, Koguchi Y, Qureshi MH, Yara S, Kinjo Y, Uezu K, Saito A. 2000. NK cells eliminate Cryptococcus neoformans by potentiating the fungicidal activity of macrophages rather than by directly killing them upon stimulation with IL-12 and IL-18. Microbiol. Immunol. 44:1043-1050.
21. Naume B, Gately MK, Desai BB, Sundan A, Espevik T. 1993. Synergistic effects of interleukin 4 and interleukin 12 on NK cell proliferation. Cytokine 5:38-46.
22. Naume B, Johnsen AC, Espevik T, Sundan A. 1993. Gene expression and secretion of cytokines and cytokine receptors from highly purified CD56- natural killer cells stimulated with interleukin-2, interleukin-7 and interleukin-12. Eur. J. Immunol. 23:1831-1838.
23. Cooper MA, Fehniger TA, Caligiuri MA. 2001. The biology of human natural killer-cell subsets. Trends Immunol. 22:633-640.
24. Kunikata T, Torigoe K, Ushio S, Okura T, Ushio C, Yamauchi H, Ikeda M, Ikegami H, Kurimoto M. 1998. Constitutive and induced IL-18 receptor expression by various peripheral blood cell subsets as determined by anti-hIL-18R monoclonal antibody. Cell. Immunol. 189:135-143.
25. Zhang T, Kawakami K, Qureshi MH, Okamura H, Kurimoto M, Saito A. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65:3594-3599.
26. Horn CA, Washburn RG. 1995. Anticryptococcal activity of NK cellenriched peripheral blood lymphocytes from human immunodeficiency virus-infected subjects: Responses to interleukin-2, interferon-gamma, and interleukin-12. J. Infect. Dis. 172:1023-1027.
27. Huenecke S, Zimmermann SY, Kloess S, Esser R, Brinkmann A, Tramsen L, Koenig M, Erben S, Seidl C, Tonn T, Eggert A, Schramm A, Bader P, Klingebiel T, Lehrnbecher T, Passweg JR, Soerensen J, Schwabe D, Koehl U. 2010. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16- and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion. J. Immunother. 33:200-210.
28. DeBlaker-Hohe DF, Yamauchi A, Yu CR, Horvath-Arcidiacono JA, Bloom ET. 1995. IL-12 synergizes with IL-2 to induce lymphokineactivated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell. Immunol. 165:33-43.
29. Ni J, Miller M, Stojanovic A, Garbi N, Cerwenka A. 2012. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 209:2351-2365.
30. Gunzer M, Weishaupt C, Planelles L, Grabbe S. 2001. Two-step negative enrichment of CD4? and CD8γδ T cells from murine spleen via nylon wool adherence and an optimized antibody cocktail. J. Immunol. Methods 258:55-63.
31. Aimanianda V, Bayry J, Bozza S, Kniemeyer O, Perruccio K, Elluru SR, Clavaud C, Paris S, Brakhage AA, Kaveri SV, Romani L, Latge JP. 2009. Surface hydrophobin prevents immune recognition of airborne fungal spores. Nature 460:1117-1121.
32. Chai LY, Netea MG, Sugui J, Vonk AG, van de Sande WW, Warris A, Kwon-Chung KJ, Kullberg BJ. 2010. Aspergillus fumigatus conidial melanin modulates host cytokine response. Immunobiology 215:915-920.
33. Kozel TR, Gotschlich EC. 1982. The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129:1675-1680.
34. Rappleye CA, Eissenberg LG, Goldman WE. 2007. Histoplasma capsulatum alpha-(1,3)-glucan blocks innate immune recognition by the betaglucan receptor. Proc. Natl. Acad. Sci. U. S. A. 104:1366-1370.
35. Obata-Onai A, Hashimoto S, Onai N, Kurachi M, Nagai S, Shizuno K, Nagahata T, Matsushima K. 2002. Comprehensive gene expression analysis of human NK cells and CD8(?) T lymphocytes. Int. Immunol. 14: 1085-1098.
36. Duke RC, Persechini PM, Chang S, Liu CC, Cohen JJ, Young JD. 1989. Purified perforin induces target cell lysis but not DNA fragmentation. J. Exp. Med. 170:1451-1456.
37. Law RH, Lukoyanova N, Voskoboinik I, Caradoc-Davies TT, Baran K, Dunstone MA, D'Angelo ME, Orlova EV, Coulibaly F, Verschoor S, Browne KA, Ciccone A, Kuiper MJ, Bird PI, Trapani JA, Saibil HR, Whisstock JC. 2010. The structural basis for membrane binding and pore formation by lymphocyte perforin. Nature 468:447-451.
38. Ernst WA, Thoma-Uszynski S, Teitelbaum R, Ko C, Hanson DA, Clayberger C, Krensky AM, Leippe M, Bloom BR, Ganz T, Modlin RL. 2000. Granulysin, a T cell product, kills bacteria by altering membrane permeability. J. Immunol. 165:7102-7108.
39. Gamen S, Hanson DA, Kaspar A, Naval J, Krensky AM, Anel A. 1998. Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways. J. Immunol. 161:1758-1764.
40. Kaspar AA, Okada S, Kumar J, Poulain FR, Drouvalakis KA, Kelekar A, Hanson DA, Kluck RM, Hitoshi Y, Johnson DE, Froelich CJ, Thompson CB, Newmeyer DD, Anel A, Clayberger C, Krensky AM. 2001. A distinct pathway of cell-mediated apoptosis initiated by granulysin. J. Immunol. 167:350-356.
41. Krensky AM, Clayberger C. 2009. Biology and clinical relevance of granulysin. Tissue Antigens 73:193-198.
42. Frohlich KU, Fussi H, Ruckenstuhl C. 2007. Yeast apoptosis-from genes to pathways. Semin. Cancer Biol. 17:112-121.
43. Nabavi N, Murphy JW. 1986. Antibody-dependent natural killer cellmediated growth inhibition of Cryptococcus neoformans. Infect. Immun. 51:556-562.
44. Koehn TA, Trimble LL, Alderson KL, Erbe AK, McDowell KA, Grzywacz B, Hank JA, Sondel PM. 2012. Increasing the clinical efficacy of NK and antibody-mediated cancer immunotherapy: Potential predictors of successful clinical outcome based on observations in high-risk neuroblastoma. Front. Pharmacol. 3:91. doi:10.3389/fphar.2012.00091.
45. Richardson MD, Brownlie CE, Shankland GS. 1992. Enhanced phagocytosis and intracellular killing of Candida albicans by GM-CSF-activated human neutrophils. J. Med. Vet. Mycol. 30:433-441.
46. Marodi L, Schreiber S, Anderson DC, MacDermott RP, Korchak HM, Johnston RB, Jr. 1993. Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J. Clin. Invest. 91:2596-2601.
47. Homey B, Muller A, Zlotnik A. 2002. Chemokines: Agents for the immunotherapy of cancer? Nat. Rev. Immunol. 2:175-184.
48. Boehm U, Klamp T, Groot M, Howard JC. 1997. Cellular responses to interferon-gamma. Annu. Rev. Immunol. 15:749-795.
49. Romani L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23.
50. Ramirez-Ortiz ZG, Lee CK, Wang JP, Boon L, Specht CA, Levitz SM. 2011.Anonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 9:415-424.
51. Vitale M, Della Chiesa M, Carlomagno S, Pende D, Arico M, Moretta L, Moretta A. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106:566-571.
52. Romani L. 2011. Immunity to fungal infections. Nat. Rev. Immunol. 11:275-288.
53. Park SJ, Burdick MD, Brix WK, Stoler MH, Askew DS, Strieter RM, Mehrad B. 2010. Neutropenia enhances lung dendritic cell recruitment in response to Aspergillus via a cytokine-to-chemokine amplification loop. J. Immunol. 185:6190-6197.
54. Hartigan AJ, Westwick J, Jarai G, Hogaboam CM. 2009. CCR7 deficiency on dendritic cells enhances fungal clearance in a murine model of pulmonary invasive aspergillosis. J. Immunol. 183:5171-5179.
55. Zitvogel L. 2002. Dendritic and natural killer cells cooperate in the control/ switch of innate immunity. J. Exp. Med. 195:F9-F14.
56. Roncarolo MG, Bigler M, Haanen JB, Yssel H, Bacchetta R, de Vries JE, Spits H. 1991. Natural killer cell clones can efficiently process and present protein antigens. J. Immunol. 147:781-787.
57. Abad A, Fernandez-Molina JV, Bikandi J, Ramirez A, Margareto J, Sendino J, Hernando FL, Ponton J, Garaizar J, Rementeria A. 2010. What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev. Iberoam. Micol. 27:155-182.
58. Eichner RD, Al Salami M, Wood PR, Mullbacher A. 1986. The effect of gliotoxin upon macrophage function. Int. J. Immunopharmacol. 8:789-797.
59. Mullbacher A, Eichner RD. 1984. Immunosuppression in vitro by a metabolite of a human pathogenic fungus. Proc. Natl. Acad. Sci. U. S. A. 81:3835-3837.
60. Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS, Komanduri KV. 2005. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 105:2258-2265.
61. Tsunawaki S, Yoshida LS, Nishida S, Kobayashi T, Shimoyama T. 2004. Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase. Infect. Immun. 72:3373-3382.
62. Yamada A, Kataoka T, Nagai K. 2000. The fungal metabolite gliotoxin: Immunosuppressive activity on CTL-mediated cytotoxicity. Immunol. Lett. 71:27-32.
63. Murciano C, Villamon E, O'Connor JE, Gozalbo D, Gil ML. 2006. Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect. Immun. 74:1403-1406.
64. Murphy JW, Zhou A, Wong SC. 1997. Direct interactions of human natural killer cells with Cryptococcus neoformans inhibit granulocytemacrophage colony-stimulating factor and tumor necrosis factor alpha production. Infect. Immun. 65:4564-4571.
65. Arancia G, Stringaro A, Crateri P, Torosantucci A, Ramoni C, Urbani F, Ausiello CM, Cassone A. 1998. Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell. Immunol. 186:28-38.
66. Lanier LL. 2005. NK cell recognition. Annu. Rev. Immunol. 23:225-274.
67. Braedel S, Radsak M, Einsele H, Latge JP, Michan A, Loeffler J, Haddad Z, Grigoleit U, Schild H, Hebart H. 2004. Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptors 2 and 4. Br. J. Haematol. 125:392-399.
68. Chalifour A, Jeannin P, Gauchat JF, Blaecke A, Malissard M, N'Guyen T, Thieblemont N, Delneste Y. 2004. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104:1778-1783.
69. Dostert C, Tschopp J. 2007. DEteCTINg fungal pathogens. Nat. Immunol. 8:17-18.
70. Netea MG, Gow NA, Munro CA, Bates S, Collins C, Ferwerda G, Hobson RP, Bertram G, Hughes HB, Jansen T, Jacobs L, Buurman ET, Gijzen K, Williams DL, Torensma R, McKinnon A, MacCallum DM, Odds FC, Van der Meer JW, Brown AJ, Kullberg BJ. 2006. Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors. J. Clin. Invest. 116:1642-1650.
71. Netea MG, Van der Meer JW, Kullberg BJ. 2006. Role of the dual interaction of fungal pathogens with pattern recognition receptors in the activation and modulation of host defence. Clin. Microbiol. Infect. 12: 404-409.
72. van de Veerdonk FL, Kullberg BJ, van der Meer JW, Gow NA, Netea MG. 2008. Host-microbe interactions: Innate pattern recognition of fungal pathogens. Curr. Opin. Microbiol. 11:305-312.
73. Mian MF, Lauzon NM, Andrews DW, Lichty BD, Ashkar AA. 2010. FimH can directly activate human and murine natural killer cells via TLR4. Mol. Ther. 18:1379-1388.
74. Sivori S, Falco M, Della Chiesa M, Carlomagno S, Vitale M, Moretta L, Moretta A. 2004. CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 101: 10116-10121.
75. Becker I, Salaiza N, Aguirre M, Delgado J, Carrillo-Carrasco N, Kobeh LG, Ruiz A, Cervantes R, Torres AP, Cabrera N, Gonzalez A, Maldonado C, Isibasi A. 2003. Leishmania lipophosphoglycan (LPG) activates NK cells through Toll-like receptor-2. Mol. Biochem. Parasitol. 130:65-74.
76. Benedetto N, Sabatini P, Sellitto C, Romano Carratelli C. 1988. Interleukin-2 and increased natural killer activity in mice experimentally infected with Aspergillus niger. Microbiologica 11:339-345.
77. Lipscomb MF, Alvarellos T, Toews GB, Tompkins R, Evans Z, Koo G, Kumar V. 1987. Role of natural killer cells in resistance to Cryptococcus neoformans infections in mice. Am. J. Pathol. 128:354-361.
78. Hidore MR, Murphy JW. 1986. Correlation of natural killer cell activity and clearance of Cryptococcus neoformans from mice after adoptive transfer of splenic nylon wool-nonadherent cells. Infect. Immun. 51:547-555.
79. Hidore MR, Murphy JW. 1986. Natural cellular resistance of beige mice against Cryptococcus neoformans. J. Immunol. 137:3624-3631.
80. Algarra I, Ortega E, Serrano MJ, Alvarez de Cienfuegos G, Gaforio JJ. 2002. Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol. Med. Microbiol. 33:159-163.
81. Balish E, Warner T, Pierson CJ, Bock DM, Wagner RD. 2001. Oroesophageal candidiasis is lethal for transgenic mice with combined natural killer and T-cell defects. Med. Mycol. 39:261-268.
82. Morrison BE, Park SJ, Mooney JM, Mehrad B. 2003. Chemokinemediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112:1862-1870.
83. Tewari RP, Von Behren LA. 2000. Immune responses in histoplasmosis, a prototype of respiratory mycoses. Indian J. Chest Dis. Allied Sci. 42:265-269.
84. Park SJ, Hughes MA, Burdick M, Strieter RM, Mehrad B. 2009. Early NK cell-derived IFN-gamma is essential to host defense in neutropenic invasive aspergillosis. J. Immunol. 182:4306-4312.
85. Zhou P, Freidag BL, Caldwell CC, Seder RA. 2001. Perforin is required for primary immunity to Histoplasma capsulatum. J. Immunol. 166: 1968-1974.
86. Akiba H, Motoki Y, Satoh M, Iwatsuki K, Kaneko F. 2001. Recalcitrant trichophytic granuloma associated with NK-cell deficiency in a SLE patient treated with corticosteroid. Eur. J. Dermatol. 11:58-62.
87. Green MR, Kennell AS, Larche MJ, Seifert MH, Isenberg DA, Salaman MR. 2005. Natural killer cell activity in families of patients with systemic lupus erythematosus: Demonstration of a killing defect in patients. Clin. Exp. Immunol. 141:165-173.
88. Krishnaraj R, Svanborg A. 1993. Low natural killer cell function in disseminated aspergillosis. Scand. J. Infect. Dis. 25:537-541.
89. Orange JS. 2002. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4:1545-1558.
90. Orange JS, Ballas ZK. 2006. Natural killer cells in human health and disease. Clin. Immunol. 118:1-10.
91. Ruggeri L, Mancusi A, Capanni M, Urbani E, Carotti A, Aloisi T, Stern M, Pende D, Perruccio K, Burchielli E, Topini F, Bianchi E, Aversa F, Martelli MF, Velardi A. 2007. Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: Challenging its predictive value. Blood 110:433-440.